Related Articles
Anlotinib‑induced acute myocardial infarction: A case report and literature review
Toripalimab combined with anlotinib for recurrent extensive‑stage small‑cell lung cancer: A case report
Low‑dose anlotinib combined with EGFR‑TKI can be used as an alternative for EGFR‑TKI‑resistant non‑small cell lung cancer in elderly patients
Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report
Anlotinib as a molecular targeted therapy for tumors (Review)